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Fc/R IIA polymorphism -131H/R and malaria severity in
Ghanaian children
D. Amoako-Sakyi
University of Cape Coast, Cape Coast, C/R, Ghana
Background: Plasmodium falciparum malaria still
remains a major public health problem in most parts of
the world especially in Sub Saharan Africa. Pathogenesis
of severe malaria is still not fully understood and several
factors have been suggested to play a role. Fc receptors
constitutes a crucial link between humoral and cellular
immune responses and are thought be important in the
pathogenesis of severe malaria. FcRIIA which belongs to
the family of Fc receptors are predominantly expressed
on neutrophils which have been shown to kill merozoites.
Thus variants of FcRIIA may inﬂuence the binding afﬁnity
of IgG and subsequently affect phagocytosis and parasite
clearance. On the other hand, increased binding afﬁnity
and enhanced phagocytosis can also stimulate the release
of some immune factors in quantities that are detrimental
leading to severe malaria. The objective of this study was
to investigate the role of the FcRIIA-131H/R variant in the
pathogenesis of severe malaria in Ghanaian children.
Methods: This study was a hospital based unmatched
case-control study involving 290 malaria cases and controls.
The study was conducted at the Korle-Bu Teaching Hospi-
tal in Accra, Ghana. PCR-RFLP was used to characterize
the FcRIIA-131H/R polymorphism in 210 Ghanaian children
with uncomplicated malaria, severe malaria anaemia, and
cerebral malaria.
Results: The study revealed that the 131HH genotype is
associated with susceptibility to cerebral malaria (OR = 4.0,
95% CI = 1.28—12.52; p = 0.014). The results also revealed
that carriers of the R allele had a signiﬁcantly lower par-
asitaemia (p < 0.050) than non-carriers.
Conclusion: The presence of FcRIIA-131HH which is
regarded as a low afﬁnity variant may lead to decreased
phagocytosis and poor control of parasitaemia in Ghanaian
Children. This however does not exclude the possibility that
IgG binding to the FcRIIA-131HH variant can stimulate the
release of factors that may contribute to the development
cerebral malaria.
doi:10.1016/j.ijid.2010.02.373
73.010
An animal model to study antimicrobial effects on
community-acquired methicillin-resistant Staphylococ-
cus aureus infection
M. Ip ∗, E.T.Y. Leung, C. Wong, K. To
Chinese University of Hong Kong„ Shatin, Hong Kong, China
Background: Outbreaks of Community-acquired
methicillin-resistant Staphylococcus aureus (CA-MRSA)
infections have been reported worldwide, and a main
concern is the severity of infection with fatal necrotizing
pneumonia and toxic shock. Studies showed that the
expression of virulence proteins by Staphylococcus aureus
depends on the strain types and could be modulated by
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ifferent agents including antibiotics. The objective of the
tudy was to establish a murine infection model to study
he in-vivo effects of commonly used antimicrobials on the
everity of CA-MRSA pneumonia.
Methods: 6-to-8-week-old BALB/c mice were divided into
roups of six in individually ventilated cages and injected
ith intranasal injection of a representative strain of CA-
RSA. The bacterial inoculum was titrated with varying
oncentration ranging 1× 107—5× 108 cfu, with controls
eceiving same volume of broth medium. Mice were sac-
iﬁced on Day 2, 3 and 4 of infection and the lungs were
issected, placed in formalin, embedded in parafﬁn blocks
nd sectioned for histological examination. The severity of
neumonia was scored according to size of leukocyte inﬁl-
ration and level of alveolar integrity and epidermis damage.
ubinhibitory concentrations of antimicrobial agents (half
f MIC per body weight) of vancomycin, ciproﬂoxacin, gen-
amicin were administered at different timepoints after
acterial inoculation.
Results: The severity of pneumonia varies with the bacte-
ial inocula titrated. All infected mice developed pneumonia
fter 24 hours of infection after inoculation of at least
× 108 cfu bacteria. The endpoint for outcome of pneu-
onia was interpreted at 24 hours. Incubation of 48 and
2 hours led to increasing mortality of mice and masked
he histological effects of pneumonia. The most signiﬁcant
ffects was in the ciproﬂoxacin group, with 33% (2/6) mice
n ciproﬂoxacin-treated group died and the the remainder
4/6) developed severe pneumonia of Grade 5 histologically
in terms of size and extent of necrotizing lesions) than
he infected control group. The non-infected-control group
emained healthy.
Conclusion: A murine model for CA-MRSA pneumonia
o study effects of different drugs was established. The
hoice of antimicrobials that minimizes release of toxins and
educes the severity of pneumonia is an invaluable approach
n improving treatment outcome in CAMRSA infections.
oi:10.1016/j.ijid.2010.02.374
3.011
ncreased killing of liver NK cells by Fas/FasL and
KG2D/NKG2DL contributes to hepatocyte necrosis in
irus-induced liver failure
. Chen1, Y. Zou1, M. Han1, H. Wang1, W. Yan1, G. Song1,
. Wu1, X. Wang1, C. Zhu1, X. Luo2, Q. Ning1,∗
Tongji Hospital, Tongji Medical College, Huazhong Univer-
ity of Science & Technology, Wuhan, Hubei, China
Tonji Hospital, Wuhan, China
Background: The role of liver NK cells in virus-induced
evere viral hepatitis and subsequently hepatic failure is not
ell deﬁned.
Methods: In this study, we investigated the role of liver
K cells in the development of hepatocyte necrosis in fulmi-
ant hepatic failure (FHF) and acute-on-chronic liver failure
ACLF) due to viral infection. A mouse model of FHF induced
y murine hepatitis virus strain 3 (MHV-3) was used to study
he role of liver NK cells. Samples from patients with hepati-
is B virus-related acute-on-chronic liver failure (HBV-ACLF)
ere examined.
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viral hepatitis model and provide insights into a potential340 14
Results: Following MHV-3 infection, the number of NK
ells in livers of Balb/cJ mice increased markedly, peaked at
8 h post-infection, and remained at a high level until sac-
iﬁce. In peripheral blood, spleen, and bone marrow, this
umber decreased signiﬁcantly. Expression of CD69, cyto-
oxic activity, and intracellular IFN-/ and TNF-& production
y liver NK cells at 48 h post-infection were all signiﬁcantly
pregulated. Highly activated liver NK cells were cytotoxic
o MHV-3-infected hepatocytes and this effect was markedly
nhibited by anti-FasL plus anti-NKG2D monoclonal antibod-
es. Furthermore, the accumulation of hepatic NK cells and
ncrease in the expression of natural cytotoxicity receptors
NKP30 and NKP46) on the peripheral NK cells from patients
ith HBV-ACLF were correlated with disease progression.
Conclusion: These results indicate the pivotal involve-
ent of NK cells in the pathogenesis of FHF and HBV-ACLF,
nd the synergetic effect of Fas-FasL and NKG2D-NKG2DL
athway in liver NK cell mediation of hepatocyte toxicity.
oi:10.1016/j.ijid.2010.02.375
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MV infection causing Adult Onset Still’s Disease: A clini-
al case
. Bento1,∗, R. Leite1, R. Tavares2, A. MIranda2, F.
entura1, C. Araújo2, K. Mansinho1
West Lisbon Hospital Centre, Lisbon, Portugal
Lisbon, Portugal
Background: CMV normally causes a mononucleosis
yndrome in immunocompetent persons. Immunologic
berrations recognized with this infection include hypogam-
aglobulinemia, rheumatoid factor (RF), antinuclear anti-
odies and anticomplementary activity. CMV has been
ssociated with inﬂammatory bowel diseases, rheumatoid
rthritis, psoriasis and Wegener’s granulomatosis. Adult
nset Still’s Disease (AOSD) is an RF-negative inﬂammatory
isorder of unknown aetiology, responsible for many cases
f fever of unknown origin. It is marked by cytokine abnor-
alities and a predominant Th1-cell response.
Methods: A 34-year-old man presented himself to the
D on June 2007 with two weeks of fever, arthralgia and
ore throat. After an empirically course with Amoxicillin
lavulanate he also experienced a self-limited morbilliform
ash. On admission he exhibited 39◦ temperature, cervical
denopathies and mild splenomegaly. Analysis showed leu-
ocytosis, atypical lymphocytosis, C-RP 3.53mg/dl and ESR
1mm/h. There was an elevation of hepatic enzymes and
ositive CMV IgM and IgG. The search for Hbs, p24 antigen
nd antibodies against HIV, HCV, EBV, Toxoplasma gondii and
treptolysin-O was negative.
Results: In October 2007 he remained symptomatic. His
iver was biopsed. Histological sections in H&E identiﬁed
pithelioid granulomas, portal inﬂammation, nuclear and
ytoplasmic inclusions in hepatocytes and Kupfer cells.
mmunohistochemistry was compatible with CMV. He was
tarted on Valganciclovir. Fever remained intermittently. In
ebruary 2008 he maintained positive titers of CMV IgM and
levated liver enzymes. The search for other infections with
ultures of peripheral blood and bone marrow was negative.
ntibodies to other agents such as Brucella spp, Borrelia
pp and Coxiella burnetii were negative. Echocardiogram,
a
a
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ody CT scan and upper and lower GI endoscopy were nor-
al. Markers for autoimmune/inﬂammatory diseases such
s ANA, ANCA and RF and tumor markers were also nega-
ive. Cytometry showed an inversed TCD4+/TCD8+ ratio and
ow CD19+ B lymphocytes. IgA, IgG and IgM levels were low.
etanus vaccination resulted in antibody response, excluding
ommon Variable Immunodeﬁciency.
Conclusion: In June 2008 he maintened fever and arthral-
ia. Analysis registered leukocytosis, ESR 77mm/h and
erritin 6400 ng/ml. CMV IgM was negative and liver enzymes
ere normal. AOSD was suspected and the patient started
rednisone 1mg/kg/day. The patient had a marked improve-
ent after institution of this therapy.
oi:10.1016/j.ijid.2010.02.376
3.013
elbivudine preserves Th1 cytokine response and down
egulates PD-L1 in MHV-3—induced viral hepatitis model
. Wu1, W. Yan1, W. Guo1, Y. Zou1, H. Wang1, X. Wang1, X.
ang1, Y. Lu1, X. Luo2, Q. Ning1,∗
Tongji Hospital, Tongji Medical College, Huazhong Univer-
ity of Science & Technology, Wuhan, Hubei, China
Tonji Hospital, Wuhan, China
Background: Telbivudine is an orally bioavailable L-
ucleoside with potent and speciﬁc anti—hepatitis B virus
HBV) activity. Recent studies have suggested a potential
mmunomodulatory effect of telbivudine. To address this,
e sought to determine the effect of telbivudine on the
mmune system, particularly cytokine production and T-cell
esponse, in the mouse hepatitis virus strain 3 (MHV-3)-
nduced hepatitis model.
Methods: The effect of telbivudine on virus replication
nd cytokines production in MHV-3 infected macrophages
ere investigated. In vivo the T cell response to Telbivudine
reatment were also studied in MHV-3 induced viral hepatitis
odel.
Results: In vitro there was no signiﬁcant difference
n MHV-3 replication in macrophages with or without tel-
ivudine treatment. The production of tumor necrosis
actor—& and interleukin-12 was increased signiﬁcantly in
HV-3—inducedmacrophages with telbivudine treatment. In
ivo survival was enhanced in telbivudine-treated mice with
arked normalization in clinical conditions and histologic
esions. Serum levels of interferon-/ were elevated signiﬁ-
antly after telbivudine treatment in MHV-3—infected C3H
ice. In contrast, serum interleukin-4 levels were decreased
igniﬁcantly. Furthermore, telbivudine treatment had a ben-
ﬁcial effect on T cells, restoring their ability to undergo
roliferation and secrete cytokines but not to enhance cyto-
oxicity on infected hepatocytes. Notably, we found that
elbivudine treatment suppressed programmed death ligand
expression on T cells.
Conclusion: These data identify an immunomodulatory
echanism of telbivudine treatment in the MHV-3—induceddditional mode of action for the management of viral hep-
titis infection.
oi:10.1016/j.ijid.2010.02.377
